Surgery Utilization Mediates Survival in Patients With Dementia and Stage I–III Colorectal Cancer
- 1Surgical Outcomes and Quality Improvement Center Indiana University Indianapolis Indiana USA
- 2Department of Medicine Indiana University School of Medicine Indianapolis Indiana USA
- 3Center for Aging Research Indiana University Indianapolis Indiana USA
Abstract
Background: Dementia is associated with increased mortality among patients with colorectal cancer (CRC), and they receive less invasive evaluations, chemotherapy, and surgery. The objectives of this study were to (1) compare demographics and treatment patterns among individuals with CRC with and without dementia, and (2) evaluate the relationship between dementia, surgery receipt or refusal, and survival.
Methods: The Indiana Cancer Registry was reviewed (2000–2020) for adult patients with clinical Stage I–III CRC. The diagnosis of dementia was determined by the presence by ICD‐9/10 codes. Overall survival was estimated using the Kaplan–Meier method and compared between patients with and without dementia using the log‐rank test. To assess the extent to which the association between dementia and survival was mediated by surgery utilization, a regression‐based causal mediation analysis of surgery receipt and refusal was performed, using covariates chosen a priori considered possible confounders of diagnosis, treatment, and survival.
Results: A total of 69,318 patients met the inclusion criteria; 1516 (2.1%) had dementia and 67,802 (97.8%) did not. The dementia cohort had a higher percentage of female patients (55% vs. 49%, p < 0.001) and was older, with a median age at diagnosis of 79 (vs. 69, p < 0.001). Patients without dementia had higher survival probabilities across all time points (12, 36, 60, 120, and 180 months), and the survival difference was statistically significant (p < 0.001). Receipt of surgery was a statistically significant mediator of survival in patients with dementia and CRC, with a proportion mediated of 9.6% (95% CI 6.2%–13.2%).
Conclusion: Individuals with dementia and CRC receive lower rates of surgery with higher rates of refusal. Differences in surgical utilization are a significant mediator of survival differences, emphasizing the importance of patient‐centered goals‐of‐care discussions with patients and family members to assess the benefits and burdens of surgical treatment when planning.
Related
- Preoperative lymph-node enlargement is associated with favorable survival for patients with pathological stage II colorectal cancer
- Survival Outcomes in Metastatic Colorectal Cancer Patients with BRAF Mutations Undergoing Targeted Chemotherapy: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Controlled Trials.
- Utilization of long-term care resources for people with dementia in Taiwan: a three-year cohort study
- HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer
- Geriatric Assessment-Based Stratification to Evaluate Treatment Intensity, Quality of Life, and Survival in Older Patients With Metastatic Colorectal Cancer: Protocol for a Prospective Observational Study.
BibTeX
@article{abbey2026surgery,
title = {{Surgery Utilization Mediates Survival in Patients With Dementia and Stage I–III Colorectal Cancer}},
author = {Evan M. Abbey and Vashisht V. Madabhushi and Meghan E. Lark and Brian Ruedinger and Malaz A. Boustani and Sanjay Mohanty},
journal = {Journal of the American Geriatrics Society},
year = {2026},
month = aug,
doi = {10.1111/jgs.70643},
url = {https://doi.org/10.1111/jgs.70643},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Surgery Utilization Mediates Survival in Patients With Dementia and Stage I–III Colorectal Cancer
AU - Evan M. Abbey
AU - Vashisht V. Madabhushi
AU - Meghan E. Lark
AU - Brian Ruedinger
AU - Malaz A. Boustani
AU - Sanjay Mohanty
PY - 2026
DA - 2026/08/07
JO - Journal of the American Geriatrics Society
DO - 10.1111/jgs.70643
UR - https://doi.org/10.1111/jgs.70643
AB - Background: Dementia is associated with increased mortality among patients with colorectal cancer (CRC), and they receive less invasive evaluations, chemotherapy, and surgery. The objectives of this study were to (1) compare demographics and treatment patterns among individuals with CRC with and without dementia, and (2) evaluate the relationship between dementia, surgery receipt or refusal, and survival. Methods: The Indiana Cancer Registry was reviewed (2000–2020) for adult patients with clinical Stage I–III CRC. The diagnosis of dementia was determined by the presence by ICD‐9/10 codes. Overall survival was estimated using the Kaplan–Meier method and compared between patients with and without dementia using the log‐rank test. To assess the extent to which the association between dementia and survival was mediated by surgery utilization, a regression‐based causal mediation analysis of surgery receipt and refusal was performed, using covariates chosen a priori considered possible confounders of diagnosis, treatment, and survival. Results: A total of 69,318 patients met the inclusion criteria; 1516 (2.1%) had dementia and 67,802 (97.8%) did not. The dementia cohort had a higher percentage of female patients (55% vs. 49%, p < 0.001) and was older, with a median age at diagnosis of 79 (vs. 69, p < 0.001). Patients without dementia had higher survival probabilities across all time points (12, 36, 60, 120, and 180 months), and the survival difference was statistically significant (p < 0.001). Receipt of surgery was a statistically significant mediator of survival in patients with dementia and CRC, with a proportion mediated of 9.6% (95% CI 6.2%–13.2%). Conclusion: Individuals with dementia and CRC receive lower rates of surgery with higher rates of refusal. Differences in surgical utilization are a significant mediator of survival differences, emphasizing the importance of patient‐centered goals‐of‐care discussions with patients and family members to assess the benefits and burdens of surgical treatment when planning.
SN - 0002-8614
SN - 1532-5415
ER -